Not available
Quote | Veru Inc. (NASDAQ:VERU)
Last: | $0.9599 |
---|---|
Change Percent: | -1.41% |
Open: | $0.9164 |
Close: | $0.9599 |
High: | $0.9748 |
Low: | $0.9139 |
Volume: | 1,126,410 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Veru Inc. (NASDAQ:VERU)
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
2024-06-26 07:53:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Veru (NASDAQ: VERU ) just reported results for the first quarter of 2024. Veru reported earnings per share of -8 cents. This was above the analyst estimate for EPS of -13 ...
Message Board Posts | Veru Inc. (NASDAQ:VERU)
Subject | By | Source | When |
---|---|---|---|
$VERU...............................https://stockcharts.com/h-sc/ui?s=$VERU&p=W&b= | glenn1919 | investorshub | 04/22/2023 12:20:37 PM |
Ther meme stock..good nws | Jayzp | investorshub | 04/21/2023 2:33:21 PM |
I still say in my opinion the shareholders | Alleyba1 | investorshub | 02/23/2023 3:41:42 PM |
I believe in the latest $VERU filing Blackrock | Alleyba1 | investorshub | 02/13/2023 5:42:12 PM |
$VERU.................................https://stockcharts.com/h-sc/ui?s=$VERU&p=W& | glenn1919 | investorshub | 02/10/2023 9:22:33 PM |
News, Short Squeeze, Breakout and More Instantly...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...